Profile data is unavailable for this security.
About the company
Shinva Medical Instrument Co Ltd is a China-based company principally engaged in the production and sales of medical devices and pharmaceutical equipment. The Company primarily operates its businesses through four segments. The Medical Device Products segment mainly provides infection control equipment and consumables, radiotherapy and imaging, in vitro diagnostic reagents and instruments, surgical instruments and orthopedics and other products. The Pharmaceutical Equipment Product segment mainly includes injections, biopharmaceuticals, solid preparations, traditional Chinese medicine preparations and other businesses. The Medical Services segment mainly develops specialized hospitals for hemodialysis. The Medical Commercial Products segment is mainly engaged in commercial logistics business.
- Revenue in CNY (TTM)10.12bn
- Net income in CNY692.34m
- Incorporated1993
- Employees8.21k
- LocationShinva Medical Instrument Co LtdHi-Tech Industrial Development ZoneZIBO 255086ChinaCHN
- Phone+86 5 333587766
- Fax+86 5 333587768
- Websitehttp://www.shinva.net
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOB Biotech Group Corp Ltd | 401.29m | 35.26m | 9.14bn | 550.00 | 258.28 | 11.20 | -- | 22.79 | 0.5614 | 0.5614 | 6.35 | 12.95 | 0.4102 | 1.37 | 8.23 | 729,609.80 | 3.60 | 9.94 | 4.33 | 12.10 | 61.87 | 65.30 | 8.79 | 19.53 | 0.9438 | 39.42 | 0.1192 | 32.59 | 23.10 | 14.38 | 13.64 | 3.34 | 46.19 | -- |
| Vcanbio Cell & Gene Engineering Corp Ltd | 1.59bn | 107.45m | 9.69bn | 2.21k | 87.94 | 2.68 | -- | 6.08 | 0.2354 | 0.2354 | 3.45 | 7.73 | 0.2977 | 1.90 | 2.59 | 721,260.30 | 1.90 | 1.13 | 2.68 | 1.61 | 68.10 | 67.76 | 6.38 | 3.84 | 1.48 | 7.89 | 0.0296 | 0.00 | 2.24 | 3.78 | -5.78 | 12.43 | -7.11 | -- |
| Shanghai Microport EP MedTech Co Ltd | 383.99m | 35.90m | 10.08bn | 577.00 | 280.68 | 5.82 | -- | 26.24 | 0.0763 | 0.0763 | 0.816 | 3.68 | 0.2081 | 1.30 | 7.04 | 665,493.30 | 1.95 | -- | 2.05 | -- | 57.86 | -- | 9.35 | -- | 13.82 | -- | 0.0109 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Shenzhen YHLO Biotech Co Ltd | 1.90bn | 288.64m | 10.39bn | 1.76k | 36.25 | 3.91 | -- | 5.46 | 0.5026 | 0.5026 | 3.32 | 4.66 | 0.4842 | 1.07 | 4.58 | 1,081,307.00 | 5.85 | 16.43 | 7.46 | 24.16 | 63.98 | 53.26 | 12.08 | 20.01 | 1.28 | 9.13 | 0.2474 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.05bn | 2.64k | 30.83 | 2.57 | -- | 4.94 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.11bn | 8.21k | 12.96 | 1.48 | -- | 1.10 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 11.55bn | 2.21k | 74.83 | 2.95 | -- | 8.99 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 11.91bn | 3.32k | 295.31 | 2.77 | -- | 1.41 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.30bn | 1.06k | 66.79 | 2.60 | -- | 8.76 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.31bn | 908.00 | 19.85 | 3.42 | -- | 10.50 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
Data as of Sep 13 2024. Currency figures normalised to Shinva Medical Instrument Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
13.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2024 | 15.57m | 2.69% |
| Bosera Asset Management Co., Ltd.as of 30 Sep 2023 | 13.39m | 2.31% |
| CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 2024 | 7.32m | 1.27% |
| China Southern Asset Management Co., Ltd.as of 30 Sep 2023 | 7.30m | 1.26% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 7.30m | 1.26% |
| Da Cheng Fund Management Co., Ltd.as of 30 Sep 2023 | 7.23m | 1.25% |
| Yinhua Fund Management Co., Ltd.as of 30 Sep 2023 | 7.14m | 1.23% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Sep 2023 | 6.99m | 1.21% |
| ABC-CA Fund Management Co., Ltd.as of 30 Jun 2024 | 3.11m | 0.54% |
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 2.44m | 0.42% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
